PLC GLAXOSMITHKLINE Insider Trading $NKTX Nkarta, Inc.
Get free email notifications about insider trading for PLC GLAXOSMITHKLINE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PLC GLAXOSMITHKLINE. PLC GLAXOSMITHKLINE is 10% Owner in QUEST DIAGNOSTICS INC ($DGX) and Director in QUEST DIAGNOSTICS INC ($DGX) and 10% Owner in EPIX Pharmaceuticals, Inc. ($EPIX) and 10% Owner in MAXYGEN INC ($MAXY) and 10% Owner in Innoviva, Inc. ($THRX) and in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and 10% Owner in APPLIED GENETIC TECHNOLOGIES CORP ($AGTC) and in Liquidia Technologies Inc ($LQDA) and 10% Owner in Redpoint Bio CORP ($RPBC) and in NUPATHE INC. ($PATH) and 10% Owner in Anacor Pharmaceuticals, Inc. ($ANAC) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and in Principia Biopharma Inc. ($PRNB) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in Progyny, Inc. ($PGNY) and 10% Owner in Theravance Biopharma, Inc. ($TBPH) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Fulcrum Therapeutics, Inc. ($FULC) and 10% Owner in CRISPR Therapeutics AG ($CRSP) and 10% Owner in Spero Therapeutics, Inc. ($SPRO) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC) and Director in BICYCLE THERAPEUTICS plc ($BCYC) and Director in Nkarta, Inc. ($NKTX) and Director in Pandion Therapeutics, Inc. ($PAND).
PLC GLAXOSMITHKLINE in Nkarta, Inc.
Trading Symbol: NKTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PLC GLAXOSMITHKLINE: Director
Holdings: 79,090 shares
Latest Transaction: Jul 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PLC GLAXOSMITHKLINE in Nkarta, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, ANAC, AGTC, BCYC, CCXI, CRSP, EPIX, FULC, GNCA, HTGM, THRX, LIQDA, MAXY, NKTX, PATH, PAND, PRNB, PGNY, DGX, RPBC, SPRO, TBPH, TPTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Option Exercise | A | 18.00 | 10,700 | 192,600 | 10,700 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 6,337,403 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 1,994,348 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Option Exercise | C | 0.00 | 292,663 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Buy | P | 18.00 | 833,333 | 14,999,994 | 3,150,732 | 2.3 M to 3.2 M (+35.96 %) |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 1,712,810 | 0 | 2,317,399 | 604.6 K to 2.3 M (+283.30 %) |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 525,499 | 0 | 604,589 | 79.1 K to 604.6 K (+664.43 %) |
Jul 16 2020 | NKTX | Nkarta, Inc. | GLAXOSMITHKLINE PLC | Director | Buy | C | 0.00 | 79,090 | 0 | 79,090 | 0 to 79.1 K |
Page: 1